These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 37608298)

  • 1. Engineered extracellular vesicles-like biomimetic nanoparticles as an emerging platform for targeted cancer therapy.
    Liu X; Xiao C; Xiao K
    J Nanobiotechnology; 2023 Aug; 21(1):287. PubMed ID: 37608298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physio-chemical Modifications to Re-engineer Small Extracellular Vesicles for Targeted Anticancer Therapeutics Delivery and Imaging.
    Asfiya R; Xu L; Paramanantham A; Kabytaev K; Chernatynskaya A; McCully G; Yang H; Srivastava A
    ACS Biomater Sci Eng; 2024 Feb; 10(2):697-722. PubMed ID: 38241003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicines in oral cancer: inspiration comes from extracellular vesicles and biomimetic nanoparticles.
    Bai YT; Zhang XQ; Chen XJ; Zhou G
    Nanomedicine (Lond); 2022 Oct; 17(23):1761-1778. PubMed ID: 36647844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem cell membrane, stem cell-derived exosomes and hybrid stem cell camouflaged nanoparticles: A promising biomimetic nanoplatforms for cancer theranostics.
    Khosravi N; Pishavar E; Baradaran B; Oroojalian F; Mokhtarzadeh A
    J Control Release; 2022 Aug; 348():706-722. PubMed ID: 35732250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles.
    Li A; Zhao Y; Li Y; Jiang L; Gu Y; Liu J
    Drug Deliv; 2021 Dec; 28(1):1237-1255. PubMed ID: 34142930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineered Extracellular Vesicles as a Targeted Delivery Platform for Precision Therapy.
    Sun Y; Sun F; Xu W; Qian H
    Tissue Eng Regen Med; 2023 Apr; 20(2):157-175. PubMed ID: 36637750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies.
    Jayasinghe MK; Tan M; Peng B; Yang Y; Sethi G; Pirisinu M; Le MTN
    Semin Cancer Biol; 2021 Sep; 74():62-78. PubMed ID: 33609665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles: emerging anti-cancer drugs and advanced functionalization platforms for cancer therapy.
    Wu M; Wang M; Jia H; Wu P
    Drug Deliv; 2022 Dec; 29(1):2513-2538. PubMed ID: 35915054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in Extracellular Vesicle Nanotechnology for Precision Theranostics.
    Wu Q; Fu S; Xiao H; Du J; Cheng F; Wan S; Zhu H; Li D; Peng F; Ding X; Wang L
    Adv Sci (Weinh); 2023 Jan; 10(3):e2204814. PubMed ID: 36373730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in targeted delivery vectors based on biomimetic nanoparticles.
    Chen L; Hong W; Ren W; Xu T; Qian Z; He Z
    Signal Transduct Target Ther; 2021 Jun; 6(1):225. PubMed ID: 34099630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
    Huyan T; Li H; Peng H; Chen J; Yang R; Zhang W; Li Q
    Int J Nanomedicine; 2020; 15():6485-6502. PubMed ID: 32922012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging prospects of extracellular vesicles for brain disease theranostics.
    Wang R; Wang X; Zhang Y; Zhao H; Cui J; Li J; Di L
    J Control Release; 2022 Jan; 341():844-868. PubMed ID: 34953980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy.
    Chen HY; Deng J; Wang Y; Wu CQ; Li X; Dai HW
    Acta Biomater; 2020 Aug; 112():1-13. PubMed ID: 32470527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Therapy Empowered by Extracellular Vesicle-Mediated Targeted Delivery.
    Chen Y; Huang Y; Deng Y; Liu X; Ye J; Li Q; Luo Y; Lin Y; Liang R; Wei J; Zhang J; Li Y
    Biol Pharm Bull; 2023; 46(10):1353-1364. PubMed ID: 37779037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicles as natural therapeutic agents and innate drug delivery systems for cancer treatment: Recent advances, current obstacles, and challenges for clinical translation.
    Pirisinu M; Pham TC; Zhang DX; Hong TN; Nguyen LT; Le MT
    Semin Cancer Biol; 2022 May; 80():340-355. PubMed ID: 32977006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
    Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
    Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles: a rising star for therapeutics and drug delivery.
    Du S; Guan Y; Xie A; Yan Z; Gao S; Li W; Rao L; Chen X; Chen T
    J Nanobiotechnology; 2023 Jul; 21(1):231. PubMed ID: 37475025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics.
    Armstrong JP; Holme MN; Stevens MM
    ACS Nano; 2017 Jan; 11(1):69-83. PubMed ID: 28068069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered extracellular vesicles: A new approach for targeted therapy of tumors and overcoming drug resistance.
    Ming-Kun C; Zi-Xian C; Mao-Ping C; Hong C; Zhuang-Fei C; Shan-Chao Z
    Cancer Commun (Lond); 2024 Feb; 44(2):205-225. PubMed ID: 38155418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.